SAR - BRITISH BIOTECH PLC
September 30 2003 - 7:41AM
UK Regulatory
Amvescap PLC
FORM SAR 3
Lodge with Company Announcements Office and the Panel. A copy must also be sent to the company
the shares of which are acquired.
Date of disclosure 30 SEPTEMBER 2003
DISCLOSURE UNDER RULE 3 OF THE RULES GOVERNING
SUBSTANTIAL ACQUISITIONS OF SHARES ("SARs")
Date of acquisition 29 SEPTEMBER 2003
Acquisition in ......... BRITISH BIOTECH PLC ....... (name of company)
Class of voting shares Number of shares/rights If rights over shares
(eg ordinary shares) over shares acquired acquired, as opposed
to the shares
themselves, specify
(1) nature of rights
ORDINARY 5P 469,199 -
Resultant total holding Resultant total holding Total percentage
of voting shares (and % of rights over shares
of total voting shares (and % of total voting
(2)in issue) shares in issue)
36,897,713 (27.17%) - 36,897,713 (27.17%)
(3)Party making disclosure................ AMVESCAP PLC
(a) Name of person acquiring shares or rights over shares DISCRETIONARY
MANAGED CLIENTS OF AMVESCAP
(4) and, if different, beneficial owner
(b) Names of any other persons acting by
agreement or understanding (see SAR 5)
Signed, for and on behalf of the party named in (3) above...... A. TULLY
(Also print name of signatory)............ ANGELA TULLY
Telephone and extension number........... 020 7065 3652
Note. Under SAR 5, the holdings of and acquisitions by persons acting by
agreement or understanding must be aggregated and treated as a holding of or
acquisition by one person. Note 3 on SAR 5 requires persons who must aggregate
holdings to disclose certain disposals.
For full details of the SARs disclosure requirements, see Rules 3 and
5 of the SARs. If in doubt, contact the Panel on Takeovers and
Mergers, Monitoring Section. Tel. No: 020 7638 0129.
Email:monitoring@disclosure.org.uk